Preparing your experience, please wait…
K
Lecture slides
MANAGEMENT OF OBESITY WITH EMPHASIS OF SEMAGLUTIDE/GLP-AGONISTS
Internal Medicine
PPTX50 pages16.0 MB
Obesity is defined as an excessive accumulation of body fat that poses health risks, with a BMI of ≥30 kg/m². The document outlines various management strategies, including lifestyle changes, pharmacological interventions, and surgical options. It highlights the mechanism of action, efficacy, and safety of Semaglutide, a GLP-1 agonist, in treating obesity and its associated conditions. The presentation also discusses the importance of addressing comorbidities and the future directions in obesity management.
No account needed
Ask this resource
Answers from this document onlyMore like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Internal Medicine Lecture Notes for Medical Students
Same clinical topic · Internal Medicine
Updates on Cervical Cancer Screening
Same clinical topic · Internal Medicine
Ambulatory Board 2022 (مبادرة الصيادلة)
Same clinical topic · Internal Medicine
acute abdomen
Same clinical topic · Internal Medicine
LABORATORY TEACHING
Same clinical topic · Internal Medicine
Internal Medicine Lecture Notes for Medical Students
Same clinical topic · Internal Medicine
BACTERIAL STDs
Same clinical topic · Internal Medicine
PEMPHIGUS VULGARIS PRIMARY BLISTERING DISEASES
Same clinical topic · Internal Medicine
SYMPTOM MANAGEMENT IN PALLIATIVE CARE
Same clinical topic · Internal Medicine